Skip to main content
Caplight Logo









SingulOmics Corporation

SingulOmics Corporation

Private
Bronx, New YorkHealthcare & Life Scienceshttps://singulomics.com/

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SingulOmics Corporation is a biotechnology company that provides genomic research and single-cell sequencing services to academic and industrial communities.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

single-cell sequencingspatial transcriptomicsmultiomicsgenomics servicesbioinformatics analysiscontract research organizationCROsingle-cell RNA-seqsingle-cell ATAC-seqsomatic mutation detectionepigenomic profilingproteomicsgenomic datadrug discoverybiotech serviceslab-as-a-service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SingulOmics Corporation Comparables

Compare SingulOmics Corporation with similar companies based on industry and business-model similarity.

SingulOmics Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sirona Dx
88%
Single Cell Discoveries
87%
Admera Health
86%

SingulOmics Corporation Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Joyce Peng

Co-Founder and CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 12, 2026

    Monthly visitors increased 121% MoM, reaching 3.3K.

  • May 12, 2026

    Monthly visitors increased 32% MoM, reaching 9.2K.

SingulOmics Corporation Filings

Explore SEC and related filing metadata, where available.

SingulOmics Corporation filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SingulOmics Corporation's valuation, stock price, and market status.

Is SingulOmics Corporation a public or private company?

SingulOmics Corporation is a private company.

What is the current stock price of SingulOmics Corporation?

SingulOmics Corporation is a private company, so its shares have no public market price. Caplight tracks SingulOmics Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is SingulOmics Corporation worth (valuation)?

Valuation information for SingulOmics Corporation is not publicly available.

Can I buy SingulOmics Corporation stock?

SingulOmics Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was SingulOmics Corporation's last funding round?

Funding round information for SingulOmics Corporation is not publicly available.

Who are the main investors in SingulOmics Corporation?

Investor information for SingulOmics Corporation is not publicly disclosed.

Will SingulOmics Corporation IPO soon?

No public IPO plans have been announced for SingulOmics Corporation.

How can I track SingulOmics Corporation secondary market activity?

Caplight tracks bids, offers, and trades in SingulOmics Corporation's shares on secondary markets.

Firmographic Details

HeadquartersBronx, New York
Employee Range5
Year Founded2016
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?